Grand Pharmaceutical Group Limited (HKG: 0512)

Grand Pharmaceutical Group Statistics

Total Valuation

Grand Pharmaceutical Group has a market cap or net worth of HKD 17.58 billion. The enterprise value is 19.07 billion.

Market Cap	17.58B
Enterprise Value	19.07B

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024.

Earnings Date	Nov 19, 2024
Ex-Dividend Date	Jun 6, 2024

Share Statistics

Grand Pharmaceutical Group has 3.50 billion shares outstanding. The number of shares has decreased by -1.51% in one year.

Shares Outstanding	3.50B
Shares Change (YoY)	-1.51%
Shares Change (QoQ)	+0.77%
Owned by Insiders (%)	48.98%
Owned by Institutions (%)	9.96%
Float	1.14B

Valuation Ratios

The trailing PE ratio is 7.28 and the forward PE ratio is 8.73.

PE Ratio	7.28
Forward PE	8.73
PS Ratio	1.66
PB Ratio	1.12
P/FCF Ratio	12.12
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.46, with an EV/FCF ratio of 13.15.

EV / Earnings	7.92
EV / Sales	1.80
EV / EBITDA	5.46
EV / EBIT	6.27
EV / FCF	13.15

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.29.

Current Ratio	1.29
Quick Ratio	1.08
Debt / Equity	0.29
Debt / EBITDA	1.30
Debt / FCF	3.13
Interest Coverage	17.07

Financial Efficiency

Return on equity (ROE) is 15.93% and return on invested capital (ROIC) is 9.67%.

Return on Equity (ROE)	15.93%
Return on Assets (ROA)	8.02%
Return on Capital (ROIC)	9.67%
Revenue Per Employee	982,584
Profits Per Employee	223,535
Employee Count	10,534
Asset Turnover	0.45
Inventory Turnover	3.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.50% in the last 52 weeks. The beta is 0.71, so Grand Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+23.50%
50-Day Moving Average	4.55
200-Day Moving Average	4.27
Relative Strength Index (RSI)	56.65
Average Volume (20 Days)	4,163,625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Grand Pharmaceutical Group had revenue of HKD 10.59 billion and earned 2.41 billion in profits. Earnings per share was 0.69.

Revenue	10.59B
Gross Profit	6.25B
Operating Income	3.04B
Pretax Income	2.85B
Net Income	2.41B
EBITDA	3.43B
EBIT	3.04B
Earnings Per Share (EPS)	0.69

Balance Sheet

The company has 3.23 billion in cash and 4.54 billion in debt, giving a net cash position of -1.31 billion or -0.37 per share.

Cash & Cash Equivalents	3.23B
Total Debt	4.54B
Net Cash	-1.31B
Net Cash Per Share	-0.37
Equity (Book Value)	15.90B
Book Value Per Share	4.49
Working Capital	1.84B

Cash Flow

In the last 12 months, operating cash flow was 1.90 billion and capital expenditures -452.36 million, giving a free cash flow of 1.45 billion.

Operating Cash Flow	1.90B
Capital Expenditures	-452.36M
Free Cash Flow	1.45B
FCF Per Share	0.41

Margins

Gross margin is 59.00%, with operating and profit margins of 28.71% and 22.75%.

Gross Margin	59.00%
Operating Margin	28.71%
Pretax Margin	26.92%
Profit Margin	22.75%
EBITDA Margin	32.41%
EBIT Margin	28.71%
FCF Margin	13.70%

Dividends & Yields

This stock pays an annual dividend of 0.26, which amounts to a dividend yield of 5.18%.

Dividend Per Share	0.26
Dividend Yield	5.18%
Dividend Growth (YoY)	85.71%
Years of Dividend Growth	1
Payout Ratio	38.32%
Buyback Yield	1.51%
Shareholder Yield	6.69%
Earnings Yield	13.73%
FCF Yield	8.25%

Stock Splits

The last stock split was on April 27, 2004. It was a reverse split with a ratio of 0.05.

Last Split Date	Apr 27, 2004
Split Type	Reverse
Split Ratio	0.05

Scores

Grand Pharmaceutical Group has an Altman Z-Score of 2.47. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	n/a